BG
XENT

BlackRock Group’s Intersect ENT, Inc XENT Stock Holding History

BlackRock Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$88K Buy
7,250
+735
+11% +$9.52K ﹤0.01% 2849
2016
Q3 		$104K Buy
6,515
+315
+5% +$4.74K ﹤0.01% 2813
2016
Q2 		$80K Sell
6,200
-105
-2% -$1.64K ﹤0.01% 2838
2016
Q1 		$120K Buy
6,305
+2,385
+61% +$43.2K ﹤0.01% 2707
2015
Q4 		$88K Sell
3,920
-141
-3% -$2.79K ﹤0.01% 2718
2015
Q3 		$95K Buy
+4,061
New +$112K ﹤0.01% 2719

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Group's XENT Position: Q4 2016 in Review

BlackRock Group increased its Intersect ENT, Inc (XENT) stake by 11% in Q4 2016, buying an estimated $9.52K and bringing the position to 7,250 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #2849.

BlackRock Group first reported a position in XENT in Q3 2015 and has held it in 6 quarters since. The position peaked at $120K in Q1 2016. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

  • BlackRock Group held 7,250 shares of Intersect ENT, Inc worth $88K as of Q4 2016.
  • BlackRock Group bought 735 Intersect ENT, Inc shares in Q4 2016, an estimated $9.52K.
  • Intersect ENT, Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2849 holding.
  • BlackRock Group first reported a position in Intersect ENT, Inc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Group's Intersect ENT, Inc position peaked at $120K in Q1 2016.
  • 104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.